3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Craniopharyngioma
1
Choroid Plexus Neoplasms
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
Paclitaxel
8
pembrolizumab
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Albumin-Bound Paclitaxel
6
Pemetrexed
4
Nivolumab
4
Irinotecan
4
Everolimus
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
vosaroxin
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
Radiotherapy, Image-Guided
×
Clear all
No trials found.